Call for Applications: Research Seed Money for Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins (ACDMPV)
National Organization for Rare Disorders (NORD), With Alveolar Capillary Dysplasia Association and The David Ashwell Foundation, Announces Research Seed Money for Two Grants (up to $93,500/grant) for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) Abstract Submission Deadline: July 10th, 2014 NORD, with funding raised in coordination with the Alveolar Capillary Dysplasia Association and The David Ashwell Foundation, is accepting applications for a two-year grant, for a total of $93,500, to conduct a scientific and/or clinical research study related to A...
Source: ScanGrants feed - June 24, 2014 Category: Research Authors: National Organization for Rare Disorders/Alveolar Capillary Dysplasia Association/David Ashwell Foundation Source Type: funding
International Society for Heart & Lung Transplantation/Bayer Pulmonary Hypertension Research Grant Award
International Society for Heart & Lung Transplantation/Bayer Pulmonary Hypertension Research Grant Award The ISHLT/Bayer Pulmonary Hypertension Research Grant Award is a two-year award in the amount of $100,000 ($50,000 per year). The APPLICATION DEADLINE is JUNE 2, 2014. AWARD DECISION AND NOTIFICATION: JULY 15, 2014. If you have any questions about the application process, please contact Phyllis Glenn at 972-490-9495 or phyllis.glenn@ishlt.org. PURPOSE: The purpose of the Award is to further the scientific understanding of Pulmonary Hypertension, with the ultimate aim of improving patient's li...
Source: ScanGrants feed - May 8, 2014 Category: Research Authors: International Society for Heart & Lung Transplantation Source Type: funding
Robyn Barst Pediatric Pulmonary Hypertension Research and Mentoring Awards
The Pulmonary Hypertension Association is proud to offer this unique mentoring and research opportunity in pediatric pulmonary arterial hypertension. Awards Robyn Barst Fund - 2014 RFAGrants from the Barst Fund will provide support for a one year mentorship for young clinicians and researchers in the field of pediatric PAH. Grantees will be expected to engage with an experienced mentor who is able to provide oversight and training in pediatric PAH treatment, management and research. In addition to the mentor component, it is expected that grantees will complete a proof of concept research project. These novel ...
Source: ScanGrants feed - May 6, 2014 Category: Research Authors: Pulmonary Hypertension Association Source Type: funding
Pulmonary Hypertension Association Proof of Concept Research Grants
Three Proof of Concept awards will be offered in 2014. These grants will support new research projects that are in the early exploratory and developmental stages and have the potential to lead to advances in the scientific understanding of PH. Proposed projects should result in preliminary data that will enable the investigator to apply for support for a larger, hypotheses-driven research project. Applicants may request up to $40,000 in direct costs for one year to be used for salaries and/or supplies to conduct this research. Investigators based in the U.S. and abroad are encouraged to apply. PHA has contracted w...
Source: ScanGrants feed - May 6, 2014 Category: Research Authors: Pulmonary Hypertension Association Source Type: funding
Pulmonary Hypertension Association/American Thoracic Society Research Fellowship in Pulmonary Arterial Hypertension
The Pulmonary Hypertension Association is partnering with the American Thoracic Society (ATS) to support faculty-level researchers in the field of pulmonary arterial hypertension. This research fellowship has been made possible by fellowships from the Pulmonary Hypertension Association. PHA serves as one of the ATS Public Advisory Roundtable members. Awards A primary goal of this research program is to enable new faculty-level investigators to make the transition to established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators ...
Source: ScanGrants feed - May 6, 2014 Category: Research Authors: Pulmonary Hypertension Association/American Thoracic Society Source Type: funding
Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)
The objectives of this project are to conduct a prospective PK/PD study in hypertensive patients to link the PK profiles to the time-course of PD activity of metoprolol, therefore, to identify the key product attributes and patient factors that may impact the therapeutic equivalence of metoprolol products. The specific objectives of the study were to:
1) Evaluate the PK-PD relationship;
2) Evaluate the effect of treatment (before and after switching metoprolol products) on the PK-PD relationship;
3) Evaluate the effect of pH variation in the population and rate of delivery on the PK-PD relationship;
4) Evaluate th...
Source: Grants.gov - April 18, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding
Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
Application Deadline: August 01, 2014 The Program is designed to support basic science and clinical research in the field of pulmonary arterial hypertension. Areas of research may include, but are not limited to: Basic science underlying PAH Genetics of PAH Pathophysiology of PAH Epidemiology of PAH Techniques for early diagnosis of PAH The Program is designed to support new original research. Proposals with significant scientific overlap with funded research projects from a peer review agency or industry source will not be considered. Eligibility Applicants must meet the following ...
Source: ScanGrants feed - April 14, 2014 Category: Research Authors: Gilead Sciences Source Type: funding
CHEST Foundation 2014 Grants and Awards Program
Each year, The CHEST Foundation offers CHEST members grants for clinical and translational research, leadership, and volunteer community service. Nearly 800 recipients worldwide have received more than $9 million to support and recognize outstanding work in chest medicine. Application deadline: May 31 For more information, contact: Dr. Sydney Parker, Director, Grants and Awards Phone: 224/521-9528 sparker@chestnet.org Distinguished Scholar in Thrombosis Grant GlaxoSmithKline Distinguished Scholar in Thrombosis $150,000 awarded over 3 years Application Deadline: May 31 The Distinguis...
Source: ScanGrants feed - March 17, 2014 Category: Research Authors: CHEST Foundation Source Type: funding
Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
Funding Opportunity Number: PA-14-114 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationFood and NutritionHealthCFDA Number: 93.24293.27393.27993.36193.39993.83793.84793.866Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized t...
Source: Grants.gov - March 4, 2014 Category: Research Tags: Education Food and Nutrition Health Source Type: funding
Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
Funding Opportunity PA-14-114 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that propose to use a common conceptual model to develop behavioral interventions to modify health behaviors and improve health outcomes in patients with comorbid chronic diseases and health conditions. Specifically, this FOA will support research in primary care that uses a multi-disease care management approach to behavioral interventions with high potential impact to improve patient-level health outcomes for individuals with three or more chronic hea...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 24, 2014 Category: Research Source Type: funding
Call for Early Career Investigator and Underrepresented Minority Travel Fellowship Applications: Targeting VEGF-Mediated Tumor Angiogenesis in Cancer Therapy
June 19 - 20, 2014 The New York Academy of Sciences A decade after the first cancer drug targeting VEGF signaling in tumor blood vessel formation received approval by the US Food and Drug Administration (FDA), significant effort has been dedicated toward progressing the research, development, and clinical application of anti-angiogenic cancer therapies. Drawing on lessons learned from successes and failures, this conference will examine ways to improve cancer therapy by addressing urgent issues such as: i. inherent /acquired resistance, ii. immunomodulation, iii. enhanced invasiveness / metastasi...
Source: ScanGrants feed - January 6, 2014 Category: Research Authors: New York Academy of Sciences Source Type: funding
Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics: Clinical Centers (CC) (U01)
Funding Opportunity Number: RFA-HL-14-027 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.838Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) s...
Source: Grants.gov - November 28, 2013 Category: Research Tags: Health Source Type: funding
Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics: Data Coordinating Center (DCC) (U01)
Funding Opportunity Number: RFA-HL-14-030 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.838Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) s...
Source: Grants.gov - November 28, 2013 Category: Research Tags: Health Source Type: funding
Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics: Data Coordinating Center (DCC) (U01)
Funding Opportunity RFA-HL-14-030 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in a new NHLBI Pulmonary Vascular Disease Phenomics Program (hereafter referred to as "PVDOMICS"). Teams of investigators will perform comprehensive, deep phenotyping across the current World Health Organization (WHO)-classified pulmonary hypertension (PH) clinical Groups 1 through 5 (http://www.nhlbi.nih.gov/health/health-topics/topics/pah/types.html), which will lead to novel subclassifications of patients with pulmonary vascular-right ve...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2013 Category: Research Source Type: funding
Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics: Clinical Centers (CC) (U01)
Funding Opportunity RFA-HL-14-027 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in a new NHLBI Pulmonary Vascular Disease Phenomics Program (hereafter referred to as "PVDOMICS"). Teams of investigators will perform comprehensive, deep phenotyping across the current World Health Organization (WHO)-classified pulmonary hypertension (PH) clinical Groups 1 through 5 (http://www.nhlbi.nih.gov/health/health-topics/topics/pah/types.html). This program will consist of up to five clinical centers (CCs) and one data coordinatin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2013 Category: Research Source Type: funding
